酒精性肝病患者肝功能评估方法
摘要
酒精性肝病的发病率和死亡率在我国呈迅速增长的趋势,成为仅次于病毒性肝炎的第二大肝病。真实、客观地判断酒精性肝病的病情,能为临床医生选择个体化治疗方案及判断预后提供有力的依据。本文介绍了酒精性肝病的各种评估方法。
出处
《实用肝脏病杂志》
CAS
2012年第3期200-202,共3页
Journal of Practical Hepatology
参考文献22
-
1Vanlemmens C,Dimartino V,Milan C,et al. Immediate listing for liver transplantation versus stage B alcoholic cirrhosis:a Med,2009,150(3):153-161. standaard care for Child-Pugh randomized trial. Ann Intern.
-
2Pugh RN,Murraylyon IM,Dawson JL,et al. Transection of the oesophagus for bleeding esophageal varices. Br J Surg, 1973,60(8) :646-649.
-
3邱德凯.不断改进肝脏储备功能检测的研究[J].中华消化杂志,2007,27(6):361-362. 被引量：5
-
4Strahl S,Maier KP. Risk-classification in liver cirrhosis. Praxis (Bern 1994),2006,95(34) : 1275-1281.
-
5Kamath PS,Wiesner RH,Malinchoc M,et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001,33 ( 2 ) : 464-470.
-
6Srikureja W,Kyulo NL,Runyon BA,et al. MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis. J Hepatol, 2005,42(5 ) : 700-706.
-
7Huo TI,Lee SD,Lin HC. Selecting an optimal prognostic system for liver cirrhosis:the model for end-stage liver disease and beyond. Liver Int, 2008,28(5 ) : 606-613.
-
8Tsai MH,Peng YS,Chen YC,et al. Low serum concentration of apolipoprotein A-1 is an indicator for poor prognosis in cirrhotic patients with severe sepsis. J Hepatol,2009,50(5), 906-915.
-
9Biggins SW,Rodriguex HJ,Bacchetti P,et al. Serum sodium predicts mortality in patients listed for liver transplantation.Hepatology,2005,41 ( 1 ) : 32-39,.
-
10Luca A,Angermayr B,Bertolini G,et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl, 2007,13(8) : 1174-1180.
二级参考文献7
-
1Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973, 60:646-649.
-
2Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33:464-470.
-
3Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl, 2001, 7 : 567-580.
-
4Freetman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl, 2002, 8:851-858.
-
5Kamath PS, Kim WR. Is the change in MELD score a better indicator of mortality than baseline MELD score? Liver Transpl, 2003, 9:19-21.
-
6Merion RM, Wolfe RA, Dykstra DM, et al. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl, 2003, 9:12-18.
-
7Huo TI, Wu JC, Lin HC, et al. Evaluation of the increase in model for end-stage liver disease (Delta MELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol, 2005, 42:826-832.
共引文献4
-
1刘菲,蔡玲燕,陈锡美.肝功能评估模型的演变[J].国际消化病杂志,2009,29(4):268-270. 被引量：3
-
2邱春华,韩盛玺,张志宏,杨靖逸.失代偿期肝硬化肝脏储备功能及预后的评估[J].西部医学,2009,21(10):1681-1684.
-
3李运东,高月求,吴眉,乐敏,陈建杰.健脾磨积解毒方联合常规西药治疗代偿期丙型肝炎肝硬化的临床研究[J].上海中医药杂志,2018,52(7):48-51. 被引量：6
-
4陈斯良,胡朋,林志鹏,赵剑波.TIPS术后短期总胆红素显著升高的相关因素分析及其对生存预后的影响[J].中华介入放射学电子杂志,2018,6(1):40-45. 被引量：5
-
1谷国强,崔炜.心房颤动的药物预防[J].国际心血管病杂志,2008,35(2):87-90.
-
2李晶莹,陆伦根.终末期肝病模型对肝硬化患者预后评估价值的研究进展[J].临床肝胆病杂志,2011,27(7):768-771. 被引量：7
-
3余光明.老年高血压患者用药先查肾[J].中国家庭医生,2006(01S):12-12.
-
4郑方算,田飒.对一例糖尿病肾病合并高血压和心衰病人的用药分析及药学服务[J].药学服务与研究,2010,10(2):102-104. 被引量：5
-
5徐承华,杨玉雯.药物基因组学研究与高血压病的个体化用药[J].心脏杂志,2010,22(3):441-443. 被引量：1
-
6王士雯,曹雪滨.注重老年高血压规范化治疗,提高降压治疗质量[J].中华老年多器官疾病杂志,2009,8(5):388-391. 被引量：5
-
7魏玉静,赵阳,夏德运.恶性血液病并发肺结核的治疗探讨[J].白血病．淋巴瘤,2001,10(1):44-45.
-
8冷为.浅析糖化血红蛋白与空腹血糖的关系[J].中国医药指南,2013,11(28):114-115. 被引量：2
-
9周洁,姬秋和.肠促胰素类药物的心血管安全性评价[J].药品评价,2014,11(21):27-33.
-
10郭坚,陈上云,劳干诚,谢彬,刘薇,林燕珊.以真胰岛素水平指导2型糖尿病治疗的探讨[J].实用医学杂志,2002,18(2):159-160. 被引量：1
